Biomarkers in Metabolic Diseases, 2nd Edition

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biomarkers".

Deadline for manuscript submissions: 30 November 2024 | Viewed by 68

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pediatrics, Nutrition and Metabolic Diseases, The Children’s Memorial Health Institute, Al. Dzieci Polskich 20, 04-730 Warsaw, Poland
Interests: inborn errors of metabolism (IEM); lysosomal storage disorders (LSD)
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Institute of Clinical Sciences, Maria Skłodowska-Curie Medical Academy, Warsaw, Poland
Interests: inborn errors of metabolism (IEM); lysosomal storage disorders (LSDs); congenital disorders of glycosylation (CDG); liver monogenic diseases; next-generation sequencing (NGS)
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Biomarkers are broadly defined as biological indicators, the study of which allows for the qualitative and quantitative assessment of various characteristics and biological states. In congenital metabolic diseases, biomarkers represent a useful biochemical tool for precise and relatively straightforward diagnosis to determine the probability of disease occurrence and its progression, as well as assess the efficacy of therapy. Biomarkers can be measured using a variety of techniques in biochemistry, genetics, proteomics, and imaging. In this way, they are an invaluable and dynamically develo** source of biomedical knowledge. Of particular importance are the quantitative biomarkers that correlate with clinical manifestations enabling the determination of risk complications or survival (surrogate biomarkers). Surrogate biomarkers also play a key role in the drug licensing process and in monitoring the effects of therapy on rare diseases, i.e., genetically determined metabolic diseases.

The small number of patients and the clinical heterogeneity of the underlying pathology require reliable, adequate, and objective parameters, which are particularly important in progressive diseases such as metabolic disorders. Pure clinical studies are outside the scopes of the Special Issue. The scope is mainly focused on basic science, in vitro, in vivo, and preclinical research, while purely clinical studies are usually not processed.

Our Special Issue aims to share new knowledge in the use and study of biomarkers in diagnosing and monitoring congenital metabolic diseases.

Prof. Dr. Anna Tylki-Szymańska
Dr. Patryk Lipiński
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at mdpi.longhoe.net by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • metabolic disorders
  • inborn errors of metabolism
  • surrogate biomarkers
  • biochemical markers
  • diagnostic markers
  • newborn screening
  • molecular analyses
  • metabolomics
  • disease progression
  • treatment efficacy

Related Special Issue

Published Papers

This special issue is now open for submission.
Back to TopTop